IL-7 receptor α chain expression distinguishes functional subsets of virus-specific human CD8+ T cells

Blood

Volumn 106, Issue 6, 2005, Pages 2091-2098

  Van Leeuwen, Ester M M ^a   De Bree, Godelieve J ^b   Remmerswaal, Ester B M ^b   Yong, Si La ^b   Tesselaar, Kiki ^b   Ten Berge, Ineke J M ^b   Van Lier, René A W ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; PEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HELPER CELL; HERPES VIRUS; HUMAN; HUMAN CELL; INFLUENZA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

EID: 24744444751     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0449     Document Type: Article

References (44)

1. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002;2:251-262.
2. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177-187.
3. Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med. 1999;189:701-710.
4. Bachmann MF, Barner M, Viola A, Kopf M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol. 1999;29:291-299.
5. Swanson BJ, Murakami M, Mitchell TC, Kappler J, Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity. 2002;17:605-615.
6. Veiga-Femandes H, Walter U, Bourgeois C, McLean A, Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol. 2000;1:47-53.
7. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol. 2001;2:415-422.
8. van Stipdonk MJ, Lemmens EE, Schoenberger SP. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol. 2001;2:423-429.
9. Badovinac VP, Porter BB, Harty JT. Programmed contraction of CD8(+) T cells after infection. Nat Immunol. 2002;3:619-626.
10. + T lymphocytes. Nature. 2003;421:852-856.
11. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337-339.
12. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339-342.
13. + T cells after acute infection. Nat Immunol. 2004;5:927-933.
14. Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191-1198.
15. + memory T cell subsets. Proc Natl Acad Sci U S A. 2004;101:5610-5615.
16. Madakamutil LT, Christen U, Lena CJ, et al. CD8αα-mediated survival and differentiation of CD8 memory T cell precursors. Science. 2004;304:590-593.
17. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 1994;369:648-652.
18. Murali-Krishna K, Lau LL, Sambhara S, et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 1999;286:1377-1381.
19. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1:426-432.
20. Becker TC, Wherry EJ, Boone D, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195:1541-1548.
21. + T cells in vivo by IL-15. Immunity. 1998;8:591-599.
22. + T cells. J Exp Med. 2002;195:1533-1539.
23. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003;3:269-279.
24. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
25. Gamadia LE, Rentenaar RJ, Baars PA, et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood. 2001;98:754-761.
26. Lundin J, Kimby E, Bjorkholm M, et al. Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). Blood. 2002;100:768-773.
27. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992;53:68-72.
28. Boom R, Sol C, Weel J, et al. A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J Clin Microbiol. 1999;37:1489-1497.
29. He X, Janeway CA Jr, Levine M, et al. Dual receptor T cells extend the immune repertoire for foreign antigens. Nat Immunol. 2002;3:127-134.
30. Rentenaar RJ, Gamadia LE, van der Hoek N, et al. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest. 2000;105:541-548.
31. + T cells in protection against CMV disease. Blood. 2003;101:2686-2692.
32. Gamadia LE, van Leeuwen EM, Remmerswaal EB, et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol. 2004;172:6107-6114.
33. + T cells. J Exp Med. 1997;186:1407-1418.
34. Park JH, Yu Q, Erman B, et al. Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity. 2004;21:289-302.
35. + T-cell responses in the elderly. J Infect Dis. 2005;191:1710-1718.
36. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A. 1998;95:3810-3815.
37. + T cells. J Exp Med. 2002;195:1515-1522.
38. Wills MR, Okecha G, Weekes MP, et al. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol. 2002;168:5455-5464.
39. + T cells. J Immunol. 2002;169:5838-5843.
40. Wallace DL, Zhang Y, Ghattas H, et al. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J Immunol. 2004;173:1787-1794.
41. Foxwell BM, Taylor-Fishwick DA, Simon JL, Page TH, Londei M. Activation induced changes in expression and structure of the IL-7 receptor on human T cells. Int Immunol. 1992;4:277-282.
42. - T cells in B-CLL. Blood. 2003;102:1057-1063.
43. +, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol. 2004;173:1834-1841.
44. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci U S A. 2004;101:16004-16009.